financial analysis method

profilecincletvfkru
johnson__johnson.doc

Financial Statement for Johnson & Johnson for the year ended 2015

(All figures are in Dollars in Millions except ratios)

· total current assets = 60,210

· total current liabilities = 27,747

· current ratio for JNJ for previous two fiscal years

2014 = 55,744/25,031= 2.23

2013= 52,800/25,643 = 2.06

· Reports on data for the last two years

Net Cash Flows from Operating Activities = 19,279

Net Cash used by Investing Activities = (7,735)

Net Cash used by Financing Activities = (10,846)

Cash and Cash Equivalents at the end of the Years = 13,732

· Create a Balance Sheet or Statement of Cash Flows for most recent two years

Johnson &Johnson Subsidiaries

Consolidated Balance sheet

Assets 2015 2014

Current assets

Cash and cash equivalents 13,732 14,523

Marketable securities 24,644 18,566

Net Account receivables trade 10,734 10,985

Inventories 8,053 8,184

Other current Assets 3,047 3,486

Total current Assets 60,210 55,744

Net property, plant and equipment 15,905 16,126

Intangible assets, net goodwill 47,393 49,054

Other non-current assets 9,903 9,434

Total assets 133,411 130,358

Liabilities and Shareholders’ Equity

Current liabilities

Loan and notes payable 7,004 3,538

Account payables 6,668 7,638

Accrued Liabilities 13,325 13,314

Accrued taxes on income 750 446

Total current liabilities 27,747 25,031

Long-term debts 12,857 15,122

Other long-term liabilities 21,657 20,453

Total Liabilities 62,261 60,606

Shareholders’ Equity

Common stock 3,120 3,120

Accumulated other incomes (13,165) (10,722)

Retained earnings 103, 879 97,245

93,834 89,643

Less: common stock held in treasury at cost 22,648 19,891

Total shareholders’ equity 71,150 69,752

Total liabilities and shareholders’ equity 133,411 130,358

· Identify trends with an indication of if the financial statements show a positive or negative for the organization and investors.

image1.emf

0

5

10

15

20

25

30

35

1st Qtr2nd Qtr3rd Qtr4th Qtr

2015

2014

Over the 2 years (2014, and 2015), Johnson & Johnson has experienced tremendous growth in profitability and assets base. 2015 is the year that the company performed better.

_1537757779.